<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP10012296B8W1" file="EP10012296W1B8.xml" lang="en" country="EP" doc-number="2301570" kind="B8" correction-code="W1" date-publ="20170125" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHU..SK....................................</B001EP><B005EP>J</B005EP><B007EP>JDIM360 Ver 1.28 (29 Oct 2014) -  2999001/0</B007EP><B078EP><date>20161028</date></B078EP></eptags></B000><B100><B110>2301570</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20170125</date></B140><B150><B151>W1</B151><B153>22</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>10012296.9</B210><B220><date>20031231</date></B220><B240><B241><date>20100930</date></B241><B242><date>20131018</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>437145 P</B310><B320><date>20021231</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20170125</date><bnum>201704</bnum></B405><B430><date>20110330</date><bnum>201113</bnum></B430><B450><date>20160127</date><bnum>201604</bnum></B450><B452EP><date>20150714</date></B452EP><B472><B475><date>20160127</date><ctry>AT</ctry><date>20160127</date><ctry>BE</ctry><date>20160127</date><ctry>CZ</ctry><date>20160127</date><ctry>DK</ctry><date>20160127</date><ctry>EE</ctry><date>20160127</date><ctry>ES</ctry><date>20160127</date><ctry>FI</ctry><date>20160428</date><ctry>GR</ctry><date>20160127</date><ctry>IT</ctry><date>20160127</date><ctry>NL</ctry><date>20160527</date><ctry>PT</ctry><date>20160127</date><ctry>RO</ctry><date>20160127</date><ctry>SE</ctry><date>20160127</date><ctry>SK</ctry></B475></B472><B480><date>20170125</date><bnum>201704</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  51/10        20060101AFI20150602BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C07K  16/28        20060101ALI20150602BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>Immunotherapie von B-zell Tumoren und Autoimmunerkrankungen unter Verwendung von unkonjugierten und konjugierten Antikörpern sowie Antikörperkombinationen und Fusionsproteinen</B542><B541>en</B541><B542>Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion protein</B542><B541>fr</B541><B542>Immunothérapie s'appliquant aux tumeurs malignes des lymphocytes B et maladies auto-immunes utilisant des anticorps non conjugués et des anticorps conjugués, des combinaisons d'anticorps et des protéines de fusion</B542></B540><B560><B561><text>WO-A-00/67796</text></B561><B561><text>WO-A-00/74718</text></B561><B561><text>WO-A-01/97855</text></B561><B561><text>WO-A-01/97858</text></B561><B561><text>WO-A-98/42378</text></B561><B561><text>WO-A1-00/67795</text></B561><B562><text>PRESS O W: "PROSPECTS FOR THE MANAGEMENT OF NON-HODGKIN'S LYMPHOMAS WITH MONOCLONAL ANTIBODIES AND IMMUNOCONJUGATES", CANCER JOURNAL FROM SCIENTIFIC AMERICAN, SCIENTIFIC AMERICAN, INC., NEW YORK, NY, US, vol. 4, no. SUPPL 2, July 1998 (1998-07), pages S19-S26, XP000929567, ISSN: 1081-4442</text></B562><B562><text>SHIH L ET AL: "Localization of an antibody to CD74 (MHC class II invariant chain) to human B cell lymphoma xenografts in nude mice.", CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII JUL 2000 LNKD- PUBMED:10941903, vol. 49, no. 4-5, July 2000 (2000-07), pages 208-216, XP002619710, ISSN: 0340-7004</text></B562><B562><text>GRIFFITHS G L ET AL: "Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 11 JUN 1999 LNKD- PUBMED:10362149, vol. 81, no. 6, 11 June 1999 (1999-06-11), pages 985-992, XP002619711, ISSN: 0020-7136</text></B562><B562><text>GOVINDAN S V ET AL: "Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.", JOURNAL OF NUCLEAR MEDICINE : OFFICIAL PUBLICATION, SOCIETY OF NUCLEAR MEDICINE DEC 2000 LNKD- PUBMED:11138697, vol. 41, no. 12, December 2000 (2000-12), pages 2089-2097, XP002619712, ISSN: 0161-5505</text></B562><B562><text>OCHAKOVSKAYA R ET AL: "Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH JUN 2001 LNKD- PUBMED:11410483, vol. 7, no. 6, June 2001 (2001-06), pages 1505-1510, XP002619713, ISSN: 1078-0432</text></B562><B562><text>PRESS O W ET AL: "Immunotherapy of Non-Hodgkin's lymphomas.", HEMATOLOGY / THE EDUCATION PROGRAM OF THE AMERICAN SOCIETY OF HEMATOLOGY. AMERICAN SOCIETY OF HEMATOLOGY. EDUCATION PROGRAM. UNITED STATES 2001, 2001, pages 221-240, XP002276291, ISSN: 1520-4391</text></B562><B562><text>TIETZE L F ET AL: "Carboranyl bisglycosides for the treatment of cancer by boron neutron capture therapy.", CHEMBIOCHEM: A EUROPEAN JOURNAL OF CHEMICAL BIOLOGY. GERMANY 4 MAY 2001, vol. 2, no. 5, 4 May 2001 (2001-05-04), pages 326-334, XP002276289, ISSN: 1439-4227</text></B562><B562><text>ILLIDGE T M ET AL: "RADIOIMMUNOTHERAPY OF CANCER: USING MONOCLONAL ANTIBODIES TO TARGET RADIOTHERAPY", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, SCHIPHOL, NL, vol. 6, no. 14, September 2000 (2000-09), pages 1399-1418, XP008020510, ISSN: 1381-6128</text></B562><B562><text>ONG G L ET AL: "Single-cell cytotoxicity with radiolabeled antibodies.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH JAN 2001 LNKD- PUBMED:11205908, vol. 7, no. 1, January 2001 (2001-01), pages 192-201, XP002619714, ISSN: 1078-0432</text></B562><B562><text>PRESTA L G: "ENGINEERING ANTIBODIES FOR THERAPY", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, BENTHAM SCIENCE PUBLISHERS, BOCA RATON,FL, US, vol. 3, no. 3, 2002, pages 237-256, XP001105189, ISSN: 1389-2010</text></B562><B562><text>REDDI ELENA: "Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B BIOLOGY, vol. 37, no. 3, 1997, pages 189-195, XP002276288, ISSN: 1011-1344</text></B562><B562><text>DE VITA SALVATORE ET AL: "Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.", ARTHRITIS AND RHEUMATISM. UNITED STATES AUG 2002, vol. 46, no. 8, August 2002 (2002-08), pages 2029-2033, XP002276292, ISSN: 0004-3591</text></B562><B562><text>STEIN R ET AL: "CD74: A new candidate target for the immunotherapy of B-cell neoplasms", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 13, no. 18, 15 September 2007 (2007-09-15), pages 5556s-5563s, XP002510850, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-07-1167</text></B562><B562><text>L. Alinari ET AL: "Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma", Blood, vol. 117, no. 17, 28 April 2011 (2011-04-28), pages 4530-4541, XP055142749, ISSN: 0006-4971, DOI: 10.1182/blood-2010-08-303354</text></B562><B562><text>GUPTA PANKAJ ET AL: "Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas", BLOOD, vol. 119, no. 16, April 2012 (2012-04), pages 3767-3778, ISSN: 0006-4971(print)</text></B562><B562><text>Pankaj Gupta ET AL: "Abstract 4572: Heterodimerization of CD74 and CD20 by two hexavalent, bispecific, anti-CD20/CD74 antibodies leads to potent cytotoxicity in mantle cell lymphoma", Cancer research, vol. 71, no. 8 Supplement, 15 April 2011 (2011-04-15), pages 4572-4572, XP055193106, ISSN: 0008-5472, DOI: 10.1158/1538-7445.AM2011-4572</text></B562></B560></B500><B600><B620><parent><pdoc><dnum><anum>03786167.1</anum><pnum>1578440</pnum></dnum><date>20031231</date></pdoc></parent></B620></B600><B700><B720><B721><snm>Goldenberg, David M.</snm><adr><str>c/o Immunomedics Inc.
300 American Road</str><city>Morris Plains
New Jersey 07950</city><ctry>US</ctry></adr></B721><B721><snm>Hansen, Hans</snm><adr><str>c/o Immunomedics Inc.
300 American Road</str><city>Morris Plains
New Jersey 07950</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Immunomedics, Inc.</snm><iid>100145131</iid><irf>I 10013 EP/D-I</irf><adr><str>300 American Road</str><city>Morris Plains, NJ 07950</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Bohmann, Armin K.</snm><iid>100046635</iid><adr><str>Bohmann 
Anwaltssozietät 
Nymphenburger Straße 1</str><city>80335 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B880><date>20110330</date><bnum>201113</bnum></B880></B800></SDOBI>
</ep-patent-document>
